OBJECTIVES: Voluntary counseling and testing (VCT) for the human immunodeficiency virus (HIV) is recommended for persons treated for tuberculosis (TB). Opportunities to diagnose HIV may be missed by limiting HIV testing to only persons diagnosed with TB. Among TB suspects in Uganda, we determined HIV prevalence, risk behaviors, and willingness to refer family for VCT. METHODS: Consenting adult patients presenting for evaluation at a referral TB clinic received same-day VCT. TB diagnosis data were abstracted from clinical records. RESULTS: Among 665 eligible patients, 565 (85%) consented to VCT. Among these, 238 (42%) were HIV-positive. Of the HIV-infected patients, 37% had received a non-TB diagnosis. HIV seroprevalence was higher in patients with a non-TB diagnosis (49%) than those diagnosed with TB (39%) (P = 0.02). Fewer than 6% of HIV-infected patients reported always using condoms with sexual partners. The majority of patients (86%) reported being 'very willing' to refer family members for VCT. CONCLUSIONS: Over 35% of HIV-infected cases in our population would have been undetected if HIV testing was limited to cases with diagnosed TB. The high HIV seroprevalence in both TB and non-TB cases merits HIV testing for all patients evaluated at TB clinics. HIV-infected TB suspects reporting high-risk behavior are at risk for HIV transmission, and should receive risk-reduction counseling.
OBJECTIVES: Voluntary counseling and testing (VCT) for the human immunodeficiency virus (HIV) is recommended for persons treated for tuberculosis (TB). Opportunities to diagnose HIV may be missed by limiting HIV testing to only persons diagnosed with TB. Among TB suspects in Uganda, we determined HIV prevalence, risk behaviors, and willingness to refer family for VCT. METHODS: Consenting adult patients presenting for evaluation at a referral TB clinic received same-day VCT. TB diagnosis data were abstracted from clinical records. RESULTS: Among 665 eligible patients, 565 (85%) consented to VCT. Among these, 238 (42%) were HIV-positive. Of the HIV-infectedpatients, 37% had received a non-TB diagnosis. HIV seroprevalence was higher in patients with a non-TB diagnosis (49%) than those diagnosed with TB (39%) (P = 0.02). Fewer than 6% of HIV-infectedpatients reported always using condoms with sexual partners. The majority of patients (86%) reported being 'very willing' to refer family members for VCT. CONCLUSIONS: Over 35% of HIV-infected cases in our population would have been undetected if HIV testing was limited to cases with diagnosed TB. The high HIV seroprevalence in both TB and non-TB cases merits HIV testing for all patients evaluated at TB clinics. HIV-infected TB suspects reporting high-risk behavior are at risk for HIV transmission, and should receive risk-reduction counseling.
Authors: S Z Wiktor; L Abouya; H Angoran; J McFarland; M Sassan-Morokro; O Tossou; D Coulibaly; I M Coulibaly; A E Greenberg Journal: Int J Tuberc Lung Dis Date: 2004-04 Impact factor: 2.373
Authors: John H Day; Alison D Grant; Katherine L Fielding; Lynn Morris; Victoria Moloi; Salome Charalambous; Adrian J Puren; Richard E Chaisson; Kevin M De Cock; Richard J Hayes; Gavin J Churchyard Journal: J Infect Dis Date: 2004-09-30 Impact factor: 5.226
Authors: S Lockman; N Hone; T A Kenyon; M Mwasekaga; M Villauthapillai; T Creek; E Zell; A Kirby; W L Thacker; D Talkington; I N Moura; N J Binkin; L Clay; J W Tappero Journal: Int J Tuberc Lung Dis Date: 2003-08 Impact factor: 2.373
Authors: Lynn Morris; Desmond J Martin; Helba Bredell; Stephina N Nyoka; Leonard Sacks; Stella Pendle; Liesl Page-Shipp; Christopher L Karp; Timothy R Sterling; Thomas C Quinn; Richard E Chaisson Journal: J Infect Dis Date: 2003-06-04 Impact factor: 5.226
Authors: C Palanivel; A M V Kumar; T Mahalakshmi; S Govindarajan; M Claassens; S Satyanarayana; D Gurumurthy; K Vasudevan; A Purty; A K Paulraj; K V Raman Journal: Public Health Action Date: 2013-09-21
Authors: Nwarbébé Barnabas Njozing; San Sebastian Miguel; Pius Muffih Tih; Anna-Karin Hurtig Journal: BMC Public Health Date: 2010-03-12 Impact factor: 3.295
Authors: Ibrahim Sendagire; Imke Schreuder; Mesach Mubiru; Maarten Schim van der Loeff; Frank Cobelens; Joseph Konde-Lule Journal: BMC Public Health Date: 2010-03-31 Impact factor: 3.295
Authors: J Lucian Davis; Laurence Huang; Joseph A Kovacs; Henry Masur; Patrick Murray; Diane V Havlir; William O Worodria; Edwin D Charlebois; Padmini Srikantiah; Adithya Cattamanchi; Charles Huber; Yvonne R Shea; Yuenwah Chow; Steven H Fischer Journal: Clin Infect Dis Date: 2009-03-15 Impact factor: 9.079